HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xing Liu Selected Research

Non-alcoholic Fatty Liver Disease

1/2021Safety and immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (CHESS2101): A multicenter study.
12/2020Exosomal miR-199a-5p promotes hepatic lipid accumulation by modulating MST1 expression and fatty acid metabolism.
1/2018Hepatic leukocyte immunoglobulin-like receptor B4 (LILRB4) attenuates nonalcoholic fatty liver disease via SHP1-TRAF6 pathway.
12/2016Relationship between grip strength and newly diagnosed nonalcoholic fatty liver disease in a large-scale adult population.
11/2016MicroRNA-124 promotes hepatic triglyceride accumulation through targeting tribbles homolog 3.
11/2016The overall computer/mobile devices usage time is related to newly diagnosed non-alcoholic fatty liver disease: a population-based study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xing Liu Research Topics

Disease

178Neoplasms (Cancer)
10/2022 - 09/2003
50Glioma (Gliomas)
06/2022 - 12/2013
49Infections
03/2022 - 04/2012
45Inflammation (Inflammations)
10/2022 - 12/2007
24Neoplasm Metastasis (Metastasis)
06/2022 - 05/2009
24Glioblastoma (Glioblastoma Multiforme)
01/2022 - 05/2014
21Hypoxia (Hypoxemia)
06/2022 - 04/2009
20Glaucoma
01/2022 - 06/2005
19Hepatocellular Carcinoma (Hepatoma)
03/2022 - 01/2009
19Hypertension (High Blood Pressure)
01/2022 - 10/2013
17Carcinogenesis
12/2021 - 01/2010
14Virus Diseases (Viral Diseases)
12/2021 - 05/2010
13Osteosarcoma (Osteogenic Sarcoma)
11/2021 - 01/2010
12Bites and Stings (Sting)
10/2022 - 12/2014
12Angle-Closure Glaucoma (Glaucoma, Angle Closure)
01/2021 - 08/2008
11Liver Neoplasms (Liver Cancer)
10/2022 - 01/2009
11Breast Neoplasms (Breast Cancer)
01/2021 - 02/2011
11Rectal Neoplasms (Rectal Cancer)
01/2021 - 01/2014
10Colorectal Neoplasms (Colorectal Cancer)
03/2022 - 10/2004
10Lung Neoplasms (Lung Cancer)
02/2022 - 05/2009
9Fibrosis (Cirrhosis)
04/2022 - 04/2009
9Sepsis (Septicemia)
01/2022 - 01/2013
9Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 02/2003
8Neurodegenerative Diseases (Neurodegenerative Disease)
07/2022 - 05/2005
8Hypospadias
07/2022 - 01/2008
8HIV Infections (HIV Infection)
03/2022 - 07/2012
8Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 10/2016
7Liver Cirrhosis (Hepatic Cirrhosis)
10/2022 - 10/2010
7Melanoma (Melanoma, Malignant)
05/2022 - 08/2002
7Thrombosis (Thrombus)
01/2022 - 04/2012
7Parkinson Disease (Parkinson's Disease)
01/2022 - 05/2005
7Atherosclerosis
01/2022 - 01/2013
7Pain (Aches)
01/2022 - 03/2012
7Obesity
08/2021 - 06/2013
6Cryptorchidism (Undescended Testes)
07/2022 - 08/2007
6COVID-19
01/2022 - 03/2020
6Colonic Neoplasms (Colon Cancer)
10/2021 - 12/2010
6Non-alcoholic Fatty Liver Disease
01/2021 - 11/2016
6Type 2 Diabetes Mellitus (MODY)
01/2021 - 08/2015
6Stomach Neoplasms (Stomach Cancer)
01/2021 - 10/2004
6Body Weight (Weight, Body)
10/2017 - 08/2002
5Insulin Resistance
12/2022 - 02/2016
5Cicatrix (Scar)
08/2022 - 03/2013
5Metabolic Diseases (Metabolic Disease)
07/2022 - 10/2016
5Rupture
05/2022 - 03/2012
5Brain Neoplasms (Brain Tumor)
02/2022 - 01/2018
5Myopia
01/2022 - 03/2003
5Chromosomal Instability (Chromosome Stability)
12/2021 - 05/2013
5Carcinoma (Carcinomatosis)
01/2020 - 12/2013

Drug/Important Bio-Agent (IBA)

73Proteins (Proteins, Gene)FDA Link
06/2022 - 05/2009
41Biomarkers (Surrogate Marker)IBA
12/2022 - 06/2014
30RNA (Ribonucleic Acid)IBA
01/2022 - 01/2013
28Biological ProductsIBA
06/2022 - 06/2009
23Pharmaceutical PreparationsIBA
10/2022 - 05/2005
23Antiviral Agents (Antivirals)IBA
01/2022 - 05/2010
19MicroRNAs (MicroRNA)IBA
01/2022 - 01/2013
18DNA (Deoxyribonucleic Acid)IBA
10/2022 - 12/2013
17InterferonsIBA
10/2022 - 09/2011
17Messenger RNA (mRNA)IBA
01/2022 - 02/2006
15Glucose (Dextrose)FDA LinkGeneric
12/2022 - 03/2014
15Transcription Factors (Transcription Factor)IBA
01/2022 - 01/2011
14Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
06/2022 - 12/2013
14Retinaldehyde (Retinal)IBA
01/2022 - 03/2002
13CytokinesIBA
10/2022 - 01/2015
11LipidsIBA
12/2022 - 12/2010
11Phosphotransferases (Kinase)IBA
01/2021 - 12/2014
9Therapeutic UsesIBA
06/2022 - 10/2004
9Long Noncoding RNAIBA
01/2021 - 01/2018
8VaccinesIBA
01/2022 - 12/2012
8SaltsIBA
01/2022 - 01/2013
8Small Interfering RNA (siRNA)IBA
03/2021 - 05/2009
8Adenosine Triphosphate (ATP)IBA
01/2021 - 02/2006
8CateninsIBA
01/2020 - 02/2011
7CollagenIBA
01/2022 - 03/2013
6Triglycerides (Triacylglycerol)IBA
12/2022 - 08/2014
6Oxygen (Dioxygen)IBA
06/2022 - 06/2017
6UbiquitinIBA
01/2022 - 12/2013
6Circular RNAIBA
01/2022 - 01/2019
6salicylhydroxamic acid (SHAM)IBA
01/2022 - 08/2007
6GasderminsIBA
01/2022 - 01/2017
6Reactive Oxygen Species (Oxygen Radicals)IBA
12/2021 - 09/2015
6Diethylhexyl Phthalate (DEHP)IBA
06/2021 - 09/2006
6Interleukin-6 (Interleukin 6)IBA
01/2021 - 10/2016
5IntegrinsIBA
08/2022 - 01/2009
5Cisplatin (Platino)FDA LinkGeneric
08/2022 - 01/2017
5Telomerase (Telomerase Reverse Transcriptase)IBA
06/2022 - 01/2016
5ErbB Receptors (EGF Receptor)IBA
06/2022 - 09/2015
5ChemokinesIBA
01/2022 - 08/2012
5Immune Checkpoint InhibitorsIBA
07/2021 - 01/2017
5SolutionsIBA
05/2021 - 01/2017
5Interferon Type IIBA
01/2021 - 05/2010
5RadonIBA
08/2020 - 01/2012

Therapy/Procedure

50Therapeutics
03/2022 - 01/2006
22Drug Therapy (Chemotherapy)
09/2022 - 02/2003
10Trabeculectomy (Trabeculoplasty)
01/2021 - 04/2009
9Neoadjuvant Therapy
01/2021 - 12/2017
8Immunotherapy
01/2022 - 01/2017
6Lasers (Laser)
08/2022 - 11/2010
5Length of Stay
12/2022 - 12/2010
5Phacoemulsification
01/2020 - 05/2002